Infusion Pump Market Size & Share, by Pump Type (Ambulatory, Enteral, Implantable, Insulin, Volumetric, PCA); Type (Stationary, Portable Pumps); Technology (Specialty, Tradition); End-user (Home Care Facility, Research Centers, Hospitals); Application (Oncology, Hematology, Analgesia, Neonatology, Gastroenterology) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

  • Report ID: 4452
  • Published Date: Feb 15, 2023
  • Report Format: PDF, PPT

Companies Dominating the Infusion Pump Landscape

top-features-companies
    • Becton, Dickinson and Company
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Baxter Healthcare Corporation
    • CODAN Medizinische Gerate GmbH & Co KG
    • Shenzhen MedRena Biotech Co., Ltd.
    • B. Braun SE
    • ICU Medical, Inc.
    • Terumo Corporation
    • Moog Inc.
    • Ypsomed Group
    • NIPRO Corporation 

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Baxter Healthcare Corporation to acquire clearance for U.S. Food and Drug Administration (FDA) for its Novum IQ syringe infusion pump. The product comes with Dose IQ safety software, the latest developments for infusion therapy. Novum IQ SYR is attached to the Connectivity Suite of Baxter’s IQ Enterprise.

  • ICU Medical, Inc. to acquire recognition as top-performing Smart Pump EMR-Integrated by KLAS Research for its Plum 360. The award is offered based on the feedback of thousands of healthcare providers and a side-by-side comparison of IV smart pumps. 


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4452
  • Published Date: Feb 15, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing number of people in the need of pain management and increasing cases of diabetes are estimated to majorly boost the market growth.

The market is anticipated to attain a CAGR of 8% over the forecast period, i.e., 2023-2033.

Lack of requisite technology such as wireless connectivity along with the rising number of medication errors and the requirement for higher initial investment are estimated to be the growth-hindering factors for the market expansion.

The market in the North America region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Becton, Dickinson and Company, Baxter Healthcare Corporation, CODAN Medizinische Gerate GmbH & Co KG, Shenzhen MedRena Biotech Co., Ltd., B. Braun SE, ICU Medical, Inc., Terumo Corporation, Moog Inc., Ypsomed Group, NIPRO Corporation, and others.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue-generating capacity as well as the new products being launched into the market by the company.

The market is segmented by pump type, type, technology, end-user, application, and by region.

The insulin segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying